These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 4026010)
1. Comparison of crystalloid and sanguineous cardioplegic solutions in the dog. Spackman CJ; Caywood DD; Gannon PG; Irmiter RA; Louis CF Am J Vet Res; 1985 Jun; 46(6):1330-4. PubMed ID: 4026010 [TBL] [Abstract][Full Text] [Related]
8. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury. Feindel CM; Tait GA; Wilson GJ; Klement P; MacGregor DC J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578 [TBL] [Abstract][Full Text] [Related]
9. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia. Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645 [TBL] [Abstract][Full Text] [Related]
10. Myocardial protection during prolonged aortic cross-clamping. Comparison of blood and crystalloid cardioplegia. Catinella FP; Cunningham JN; Spencer FC J Thorac Cardiovasc Surg; 1984 Sep; 88(3):411-23. PubMed ID: 6471891 [TBL] [Abstract][Full Text] [Related]
11. The role of cardioplegic solution buffering in myocardial protection. A biochemical and histopathological assessment. del Nido PJ; Wilson GJ; Mickle DA; Bush BG; Rebeyka IM; Klement P; Harding R; Tait GA J Thorac Cardiovasc Surg; 1985 May; 89(5):689-99. PubMed ID: 3990319 [TBL] [Abstract][Full Text] [Related]
12. Cardioplegic arrest in pigs. Effects of glucose-containing solutions. Salerno TA; Chiong MA J Thorac Cardiovasc Surg; 1980 Dec; 80(6):929-33. PubMed ID: 7431990 [TBL] [Abstract][Full Text] [Related]
14. [Myocardial protection by a carnosine-buffered cardioplegic solution (author's transl)]. Gercken G; Bischoff H; Trotz M Arzneimittelforschung; 1980; 30(12):2140-3. PubMed ID: 7194076 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of myocardial protection during blood-potassium cardioplegia: a comparison of crystalloid red cell and methemoglobin solutions. Bing OH; LaRaia PJ; Franklin A; Stoughton J; Weintraub RM Circulation; 1984 Sep; 70(3 Pt 2):I84-90. PubMed ID: 6744572 [TBL] [Abstract][Full Text] [Related]
16. The metabolic consequences of blood and crystalloid cardioplegia. Engelman RM; Rousou JH; Lemeshow S; Dobbs WA Circulation; 1981 Aug; 64(2 Pt 2):II67-74. PubMed ID: 6972829 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of myocardial protection with DBcAMP in crystalloid cardioplegic solutions]. Ishikura Y; Odagiri S; Shimazu A; Tokunaga H; Shimokawaji M; Yoshimatsu H Rinsho Kyobu Geka; 1989 Dec; 9(6):559-63. PubMed ID: 9308660 [TBL] [Abstract][Full Text] [Related]
18. Induction of cardioplegia with blood and crystalloid potassium solutions during prolonged aortic cross-clamping. Nwaneri NJ; Levitsky S; Silverman NA; Feinberg H Surgery; 1983 Nov; 94(5):836-41. PubMed ID: 6635947 [TBL] [Abstract][Full Text] [Related]
19. Cardioplegic infusion: the safe limits of pressure and temperature. Johnson RE; Dorsey LM; Moye SJ; Hatcher CR; Guyton RA J Thorac Cardiovasc Surg; 1982 Jun; 83(6):813-24. PubMed ID: 7087508 [TBL] [Abstract][Full Text] [Related]
20. Effects of coenzyme Q10 added to a potassium cardioplegic solution for myocardial protection during ischemic cardiac arrest. Mori F; Mohri H Ann Thorac Surg; 1985 Jan; 39(1):30-6. PubMed ID: 3966834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]